| Stage | Primary Treatment | Adjuvant therapy | Five-year survival rate (%) |
| Non-small cell carcinoma | |||
| I | Resection | Chemotherapy | 60 to 70 |
| II | Resection | Chemotherapy with or without radiotherapy | 40 to 50 |
| IIIA-Resectable | Resection with or without preoperative chemotherapy | Chemotherapy with or without radiotherapy | 15 to 30 |
| IIIA-Unresectable | Chemotherapy with concurrent or subsequent radiotherapy | None | 10 to 20 |
| IIIB-Pleural effusion | Chemotherapy with concurrent or subsequent radiotherapy | None | 10 to 15 |
| Small cell carcinoma | |||
| Limited disease | Chemotherapy with concurrent radiotherapy | None | 15 to 25 |
| Extensive disease | Chemotherapy | None | <5 |